Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB

• Главные авторы: Pingping Liu (Автор), Yinan Jiang (Автор), Xiaojing Zheng (Автор), Baoyue Pan (Автор), Huiling Xiang (Автор), Min Zheng (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: The systemic immune-inflammation index (SII) has been identified as a predictor of chemotherapy efficacy for a variety of cancers, and we aimed to determine its ability to predict the response to chemotherapy and its long-term prognosis for patients with cervical squamous cell carcinoma...